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Abstract
Background: Osteoporosis is an important public health problem in older adults. It is more
common in postmenopausal women and not only gives rise to morbidity but also markedly
diminishes the quality of life in this population. There is lack of information about the risk factor of
osteoporosis in developing countries. In this study we aimed to assess the risk factors for
osteoporosis in postmenopausal women from selected BMD centers of two developing Asian
countries (Iran and India).
Methods: This study is a multicenter interview-based study conducted in selected hospitals and
health centers from urban areas in Iran and India. The case group included postmenopausal
osteoporotic women who were identified as patients with bone density higher than 2.5 SD below
average of young normal bone density (in L1–L4) spine region interest and/or total femoral region)
by using DEXA method. The controls were chosen from postmenopausal women with normal
bone density (in L1–L4 spine and total femoral regions using DEXA method) matching in age groups
was strategy of choice.
The sample sizes included from Iran a total of 363 subjects (178 osteoporotic and 185 normal) and
from India a total of 354 subjects (203 osteoporotic and 151 normal).
Results: The significant (p < 0.05) risk factors in present study population with their Odds Ratios
(in parenthesis, respectively in Iran and India) were as follow:
Lower education defined as less than class 12 or nil college (2.1) (2.7), duration of menopause
greater than 5 years: (2.2) (1.4), Menarche age (after 14 years): (1.9) (1.6), Menopause age (before
45 years): (1.1) (2), Parity more than 3: (1.1) (1), Bone and joint problem (2.3) (2.2).
Calcium supplementation (0.6) and HRT (0.4) were shown as protective factors and steroid
therapy (3.3) was found as a risk factor in Iran. Calcium supplementation more than 1 year (0.3)
was shown as a protective factor in India.
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Pure vegetarianism: (2.2) and Red meat consumption more than 4 times per week (1.4) was shown
as a risk factor in Indian and Iranian subjects respectively.
Regular consumption of Soya (0.3), almond (0.5), fish (0.5), fruits (0.4) and milk tea 4 cups per day
and more (0.4) appeared to be significant protective factors in India. Regular consumption of cheese
(0.5), milk (0.5), chicken (0.4), egg (0.6), fruit (0.4), tea 7 cups per day and more (0.3) were found
to be significant protective factors in Iran. Exercises were shown as protective factor in Iran (0.4)
and India (0.4).
There were no significant differences in association of risk factors and osteoporosis between
Iranian and Indian subjects.
Conclusion: Osteoporosis in Iranian and Indian subjects also appears to be associated with several
known risk factors that well described in the literature. There were no significant differences in
association of risk factors and osteoporosis between Iranian and Indian subjects. It was shown a
protective role of certain nutritional dietary components and also exercises in both populations
and can be exploited in preventive educational strategies on osteoporosis in these populations.
Background
Osteoporosis and low bone density are significant risk fac-
tors for morbidity and mortality in older adults. These
conditions are characterized by poor bone strength and
are associated with an increased risk of the fractures from
even slightly traumatic events. Several medications have
recently been labeled for the treatment of osteoporosis,
but their marginal benefits require careful consideration
of their cost. Prevention is preferable to treatment since
no therapy fully restores lost bone mass. It is also known
that the prevalence of osteoporosis varies from country to
country, and within countries [1]. Differences in race,
nutritional status, physical activity, lifestyle and living
conditions all contribute to its variability [2]. Several
demographic factors may be considered as barriers to
health prevention like high rate of illiteracy and low soci-
oeconomic status in developing countries [3]. Other fac-
tors that may contribute to regional difference include
water hardness, sunlight exposure, poverty levels and the
proportional agricultural land. Further studies are needed
to identify the environmental factors responsible for such
marked regional difference [4].
Osteoporosis is an important public health problem in
older adults. Not only does it give rise to morbidity but
also markedly diminishes the quality of life of women
after menopause, and of both women and men over 65
years of age [5]. In the twentieth century the proportion of
older persons started to rise and is expected to continue
throughout this century. The number of individuals aged
60 and above is projected to grow to almost 2 billion by
2050, of who fifty-four percent live in Asia and the vast
majority of who will be in the developing world. Such
accelerated global population aging will increase eco-
nomic and social demands on all countries [6].
On the other hand the estimated lifetime risk of oste-
oporotic fracture is as high as 50 percent, especially in
white and Asian women. At present in India osteoporotic
fractures usually occur 10 to 20 years earlier in men and
women compared to Caucasian in the west. In Iran the
prevalence of lumbar spine osteoporosis and osteopaenia
among post-menopausal women was reported 26.7 and
50%, respectively [7].
The attainment of a higher peak bone density has an
important role in the prevention of osteoporosis later in
life [8-11]. Genetic factors and race/ethnicity have a strong
influence on peak bone density [11-14]. Physiological,
environmental and modifiable lifestyle factors can also
play a significant role [13,15]. These factors include ade-
quate nutrition and body weight [16,17], exposure to sex
hormones at puberty [18,19] and level of physical activity
[20]. They are not only important for the acquisition of
maximal bone mass but also for its maintenance through-
out life [13,21-23].
Definition and comparison of osteoporosis risk factors in
these two developing Asian countries (Iran and India)
that have some similarities and differences in culture and
life style can be useful for preventive health programs of
Osteoporosis. In this study the risk factors of osteoporosis
were compared in postmenopausal women whose bone
mineral density (BMD) were measured in selected BMD
centers of Iran and India during May 2002 to January
2005.
Methods
This study is a case-control, multicentral-based study con-
ducted in selected hospitals and health centers from
urban areas in Iran and India. The case group included
postmenopausal Osteoporotic women who were identi-
fied as patients with bone density higher than 2.5 SDBMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
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below average of young normal bone density (in L1–L4)
spine region interest and/or total femoral region) by using
DEXA method. The Controls were chosen from post-men-
opausal women with normal bone density (BMD lesser
than 1 SD below average of young's in L1–L4 spine and
total femoral regions using DEXA method) frequency of
matching in age groups was the strategy of choice.
At present study all information about BMDs comes from
DEXA method mostly using Lunar machines (in Iran
Lunar DPX and in India mostly Lunar DPX and Lunar
Prodigy)
There was little information that came from using Hologic
Delphi DEXA machine in India. This limitation does not
affect on the study results because following solutions
controlled it: 1) BMDs did not compare with each other
directly and subject divided in two osteoporotic and con-
trol (with normal BMD) groups in based of WHO defini-
tion. 2) Excluding subjects with osteopenic bone density
and making gap between cases' and controls' BMDs (there
was no chance for any overlap between cases and controls
even by using different BMD machines).
The sample was selected from all postmenopausal women
whose bone mineral density was measured in selected
centers during the study period (2002 to 2005). Among
this population all the osteoporotic women were recalled
and interviewed upon their consent to participate as case
groups. Controls were selected by recalling candidates
from a list of non-osteoporotic non-osteopenic women
created from the centers' databases during the study
period. Of women contacted for the study, 363 subjects
from Iran (178 osteoporotic and 185 normal) and 354
subjects (203 osteoporotic and 151 normal) agreed to
participate. Consent to participate was verbal for all of the
samples from the centers in Iran and India except KEM
hospital that was written because of the rules of hospital.
For control the effect of age on the study results we have
tried to match the controls with cases in 10 years groups
(table 1) but this kind of matching could not control the
effect of age completely thus we have adjusted the result
for age for tight control the effect.
Data collected for this study included filling question-
naires through personal interviews, use of case records,
files and documents. The questionnaire covered the fol-
lowing factors and information:
- Demographic characteristics including age, education,
occupation, marital status
- Menstrual and obstetrical history: menarche age, age of
menopause, parity and abortion.
- Medical condition and medication. Medical condition
included (history of endocrine disorders like diabetes and
thyroid, heart disease, kidney, asthma, and other related
medical problem) and also bone and joint disorders (in
this study included any disorders and discomfort related
to bone and joint that needs treatment and or rest)
Medication included most common related drugs and
supplements like: calcium supplementation, HRT and
steroids with at least lowest available therapeutic and/or
preventive dose that were used continuously 6 months or
more for calcium and HRT and one month or more for
steroids.
- Nutrition questionnaire: life time food frequency ques-
tionnaire and food habits.
- Physical activity, exercises, self-imagination, reporting
physical activity and standing on feet.
Table 1: Characteristics of subjects in two populations
Iran India
Case (n = 178) Control (n = 185) p-value Case (n = 203) Control (n = 151) p-value
Age(SD) 58.2(7.1) 55.7(6.0) <0.05 58.9(8.1) 56.4(7.5) <0.05
Age group (%)
<50 16(9.0) 15(8.2) 18(9.0) 19(12.8)
50–59 100(56.2) 124(67.4) NS 103(51.2) 87(58.8) NS1
60–69 55(30.9) 40(21.7) 66(32.8) 36(24.3)
>69 7(3.9) 5(2.7) 14(7.0) 6(4.1)
Anthropometric characters (SD)
Weight (Kg) 64.5(10.6) 71.9(10.0) <0.05 60.5(12.8) 71.1(11.1) <0.05
Height (Cm) 155.8(6.6) 157.1(5.6) <0.05 152.8(7.5) 157.5(6.4) <0.05
BMI 26.7(4.4) 29.2(4.5) <0.05 26.1(5.6) 29.0(4.2) <0.05
1 = Non significantBMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
Page 4 of 10
(page number not for citation purposes)
Table 2: Distribution of associated factors with osteoporosis in two populations.
Variabels1 Iran India
Case 
(n = 178)
Control
 (n = 185)
OR2 (0.95 CI) OR3 (0.95 CI) Case 
(n = 203)
Control 
(n = 151)
OR2 (0.95 CI) OR3 (0.95 CI)
Education
Subjects (n) 163 164 ---- ---- 178 124 ---- -----
<12 yrs schooling (%) 66.3 39.0 2.1 (1.7–4.3) 3.0 (1.8–5.1) 40.4 19.4 2.7 (1.5–4.8) 1.8 (0.8–4.0)
Anthropometric charcters (%)
Weight <= 60 Kg (%) 37.0 12.9 3.9 (2.3–6.7) ---- 54.9 20.0 4.8 (2.7–8.4) -----
Height <= 155 Cm (%) 46.8 40.3 1.2 (0.8–1.8) ---- 66.7 31.9 4.0 (2.3–7.2) ----
BMI <= 26 (%) 39.4 15.3 3.9 (2.3–6.7) ---- 46.2 19.8 3.6 (1.9–6.6) ----
Menopausal factors
Subjects (n) 162 183 ---- ---- 159 105 ---- ----
Menopausal age before 45 
yrs (%)
35.8 27.9 1.1 (1.04–1.1) 1.8 (1.0–3.0) 30.2 23.6 2.0 (1.2–3.5) 2.6 (1.2–5.9)
Subjects (n) 158 181 ---- ---- 160 105 ---- ----
Postmenopausal >5 yrs (%) 75.3 52.5 2.2 (1.3–3.7) 2.3 (1.3–4.0) 73.5 58.5 1.4 (0.7–2.7) 1.4 (0.6–3.2)
Subjects (n) 149 143 ---- ---- 79 64 ---- ----
Menarche after 14 yrs (%) 52.3 36.4 1.9 (1.1–1.3) 1.6 (0.9–2.6) 46.5 34.5 1.6 (0.8–3.4) 1.4 (0.5–3.9)
Subjects (n) 171 178 ---- ---- 190 141 ---- ----
Parity >= 4 (%) 49.1 63.5 1.1 (1.0–1.1) 2.0 (1.2–3.3) 20.5 12.1 1.0 (1.04–1.1) 1.2 (0.5–2.6)
Medication
Subjects (n) 178 179 ---- ---- 183 138 ---- ----
Steroid usage (%) 19.1 7.3 3.3 (1.6–6.6) 3.3 (1.6–6.6) 5.5 1.4 4.3 (0.9–20.4) NS2
Calcium 
supplementation>1 yr (%)
39.9 50.3 0.6 (0.4–0.9) 0.7 (0.4–1.0) 47.1 77.8 0.4 ((0.1–0.9) 0.2 (0.1–0.8)
HRT (%) 27.1 46.4 0.5 (0.3–0.7) 0.5 (0.3–0.7) 10.6 12.1 0.9 (0.4–1.8) 0.8 (0.3–2.4)
Other (%)
Bone and join problem 29.4 15.1 2.3 (1.4–4.0) 2.5 (1.3–4.4) 35.7 20.7 2.2 (1.63–3.7) 1.8 (1.0–3.6)
History of fracture 20.1 8.5 2.6 (1.4–5.2) 3.3 (1.6–6.9) 20.7 7.1 3.2 (1.4–7.5) 3.8 (1.2–11.9)
1 = Variables are dichotomous. 2 = Non significant. OR2 = Adjusted for age. OR3 = Adjusted for age, height
- Habits: alcohol consumption, smoking, tobacco use,
misheri
-Anthropometric characters: height, weight, BMI (weight
and height were used to be measured and recorded in all
BMD centers before measurement of bone density rou-
tinely)
Statistical analysis was performed using SPSS software. We
have used Odds Ratio for estimation the association of
risk factors with osteoporosis, Multinominal logistic
regression was the main method for adjustment of con-
founds variables. Χ2 was carried out to assess the nominal
variables and T student test were used for comparing
means of quantitative variables. The 5% level of statistical
significance was chosen.
Ethical issues
Ethic committee clearance and permission obtained
whenever based on requirement of participation center.
This study was approved by Ethics Committee of Endo-
crinology and Metabolic Research Center, Tehran univer-
sity of Medical Sciences, Iran and also Ethics Committee
for research on human subjects, Seth GsMedical College &
KEM Hospital, Mumbai, India However the following
issues were considered:
We have interviewed with patients who were agreed to
participate. The consent was written only in KEM hospital
and verbal in other centers. Identify was not revealed. The
data was kept strictly confidential. Acknowledgment each
particular centers when data published.
Results
A total 717 individuals were included (381 of them were
cases) mean age, weight and height of cases and controls
broken down by the countries are shown in table 1. There
was a good overall match between age range in two pop-
ulations Mean of weight and BMI were significantly lower
in osteoporotic group in both countries and mean of
height was significantly lower in osteoporotic group in
Indian subjects (p < 0.05) (table 1). Weight less than 60BMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
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Table 3: Distribution of nutritional associated factors with osteoporosis in two populations
Nutritional factors 1 Iran India
Case 
(n = 178)
Control 
(n = 185)
OR2 (0.95 CI) OR3 (0.95 CI) Case 
(n = 203)
Control 
(n = 151)
OR2 (0.95 CI) OR3 (0.95 CI)
Fish
Subjects (n) 151 160 ---- ---- 144 115 ---- -----
>= 2/w (%) 4 6.9 NS NS 6.9 21.7 0.5 (0.3–0.9) 0.4 (0.2–0.9)
Eggs
Subjects (n) 135 148 ---- ---- 146 115 ---- ----
>= 1/w (%) 55.6 68.9 0.6 (0.4–1.0) 0.6 (0.3–0.9) 28.1 42.6 0.5 (0.3–0.9) 0.6 (0.3–0.9)
Chicken
Subjects (n) 169 165 ---- ---- 196 145 ---- ----
>= 2/w (%) 58.6 74.5 0.4 (0.2–0.6) 0.4 (0.2–0.7) 16.7 17.1 NS2 NS
Red meat
Subjects (n) 169 165 ---- ---- 140 116 ---- ----
>= 4/w (%) 31.4 20 1.9(1.2–3.3) 1.9(1.1–3.3) 5 3.4 NS NS
Almond
Subjects (n) 149 143 ---- ---- 79 64 ---- ----
>= 4/w (%) 13.9 16.5 NS NS 17.7 32.1 0.5 (0.3–0.9) 0.4 (0.2–0.9)
Soya
Subjects (n) 135 148 ---- ---- 146 115 ---- ----
>= 4 (%) 1.2 4.3 NS NS 7.2 19.6 0.3 (0.2–0.7) 0.4 (0.2–0.9)
Fruits
Subjects (n) 166 164 ---- ---- 131 101 ---- ----
Daily (%) 72.3 84.8 0.5 (0.3–0.9) 0.5 (0.3–0.9) 74 89.1 0.4 (0.2–0.8) 0.3 (0.1–0.7)
Tea (Iran)§/milktea (India)†
Subjects (n) 172 170 ---- ---- 163 113 ---- ----
>= 7 cup/w§and >= 4 
cup/w† (%)
9.9 28.2 0.3 (0.2–0.6) 0.3 (0.1–0.5) 16.1 32.7 0.4 (0.2–0.8) 0.4 (0.2–0.9)
Milk
Subjects (n) 176 173 ---- ---- 135 112 ---- ----
>= 1 cup/day 51.1 63.0 0.5 (0.4–0.9) 0.6 (0.3–0.9) 62.2 62.5 NS2 NS2
Cheese
Subjects (n) 167 169 ---- ---- 122 108 ---- ----
>= 30 g/day 44.9 59.8 0.5 (0.4–0.8) 0.5 (0.3–0.9) 11.5 13.9 NS2 NS2
1 – Variables are dichotomous.2 – Non significant. OR2 = Adjusted for age. OR3 = Adjusted for age, height and weight
kg and BMI less than 26 have been shown as risk factors
of osteoporosis in both countries. Height less than 155 cm
has been shown as a risk factor of osteoporosis in Indian
subjects, see table 2.
Low education and husband low education and being
housewife was shown as risk factors of osteoporosis in
both populations, distribution of osteoporotic and con-
trols based on education level is shown In table 2. Educa-
tion less than 12 years of schooling remained significant
(P < 0.05) as risk factor after age, height and weight adjust-
ment in both countries.
Early menopause (before 45 years old), late menarche
(after 14 years) and post menopausal duration more than
5 years were shown as significant risk factors in both
countries. Parity more than 3 was shown as risk factor in
both populations and it remained significant (P < 0.05)
after age, height and weight adjustment in Iranian subjects
(table 2).
According to table 2, bone and joint disorders and history
of fracture during last 5 years were shown as risk factors of
osteoporosis in both populations. Prevalence of oste-
oporosis was higher in women with history of osteoporo-
sis and or fracture in their mother and sisters in both
countries.
Hormone replacement therapy (HRT) and calcium sup-
plementation in Iran and calcium supplementation more
than 1 year in India have been shown as protective factors
and medication with steroids was a risk factor for oste-
oporosis (Table 2).
Pure vegetarianism and Red meat consumption more
than 4 times per week were shown as risk factors in IndianBMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
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and Iranian subjects respectively. Regular consumption of
Soya, almond fish, fruits and milk tea 4 cups per day and
more appeared to be significant protective factors in India.
Regular consumption of cheese, milk, chicken, egg, fruit,
tea 7 cups per day and more were found to be significant
protective factors in Iran. Distribution of subjects based
on food consumption in both countries with their odds
ratios are shown in table 3. In this study exercises was
shown as protective factor in both countries and it
remained significant after adjustment for age, weight and
height in Iran. Walking and other exercises (aerobic
weight lifting, swimming and other) were shown as pro-
tective factors in Iranian subjects (table 4).
The percentage of women who were directly in sunshine
exposure at least for 15 minutes per day was significantly
higher among controls compared to osteoporotic groups
in Iranian subjects (P < 0.01). and sunshine exposure was
shown as a protective factor in Iran Odds ratio and 95%
confidence interval include 0.45 (0.28–0.72) and it
remained significant after age, weight and height adjust-
ment.
In this study frequency of smoking at least one per day in
Iranian subjects were 9% (6% in osteoporotic group and
12% in controls), in Indian subjects it was %2.6 in total.
The effective amount of cigarette smoking on osteoporo-
sis is at least 10 cigarettes per day and its frequency were
3.6% and 1.4% respectively in Iran and India. More
details of foundlings are available in tables S5 to S8 and
charts 1 and 2 (see additional file 1).
Discussions
In this study osteoporosis in Iranian and Indian subjects
appears to be associated with several known risk factors
that well described in the literature.
Aging is a major factor that affect bone mass and it was
explained in several previous studies [29,30] in this study
we have tried to control the effect of age on the study
results by sampling cases and controls in similar age
groups. But this kind of matching could not control the
effect of age completely thus we have adjusted the result
for age for tight control the effect.
Demographic factors
Results of this study show that the education level is one
of the most important demographic factors that associate
with Osteoporosis. Reverse effects of education level on
osteoporosis have been reported in some other studies
[23,24].
The reason probably is the effect of education on lifestyle,
nutrition and economic status. The other possibility is the
effect of economic status in education level. People from
well to do families have more facilities for continuing
their education and they also have better nutritional and
health status during childhood which affect the bone
mass. Illiteracy and poverty are two main problems in
heath preventive programs in Iran and India that should
mentioned in future governmental strategies.
Menstrual and obstetrical factors
Primary osteoporosis results from estrogen deprivation
and constitutes 95% of all cases. The mechanism of estro-
gen deprivation in bone mass is well describe in previous
studies [25-30]. Exposing by estrogen in longer time is
associated with lower risk of osteoporosis. Thus menstrual
factors such as late menarche age, early menopause, and
amenorrhea have been shown as risk factors of osteoporo-
sis in previous studies [31,32]. In this study Menstrual fac-
tors such as late menarche (after 14 years old), early
menopause (before 45 years old) and Postmenopausal
period more than 5 years has been shown as risk factors of
osteoporosis in both countries. In present study it was
Table 4: Association of osteoporosis with exercises as protective factors in Iran and India.
Variabels1 Iran India
Case 
(n = 178)
Control 
(n = 185)
OR2 (0.95 CI) OR3 (0.95 CI) Case 
(n = 203)
Control 
(n = 151)
OR2 (0.95 CI) OR3 (0.95 CI)
Exercises
Subjects (n) 178 185 ---- ---- 202 149 ---- -----
Yes (%) 77.0 90.8 0.4 (0.2–0.7) 0.4 (0.2–0.7) 87.2 78.1 0.4 (0.3–0.9) NS2
Other exercises
Subjects (n) 169 165 ---- ---- 146 115 ---- ----
Yes (%) 21.9 44.8 0.4 (0.2–0.6) 0.3 (0.2–0.6) 16.0 17.8 NS2 NS2
Regular walking
Subjects (n) 172 168 ---- ---- 144 113 ---- ----
Yes (%) 68.6 84.5 0.5 (0.3–0.8) 0.4 (0.2–0.8) 72.3 77.4 NS2 NS2
1 – Variables are dichotomous.2 – Non significant. OR2 = Adjusted for age. OR3 = Adjusted for age, height and weightBMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
Page 7 of 10
(page number not for citation purposes)
also indicated that multi-parity more than 3 was a risk fac-
tor for osteoporosis in both countries. On balance of the
available literature, it appears that there is a small loss of
bone throughout pregnancy, between 1 and 4%, in the
pelvis and lumbar spine. There is less than universal agree-
ment about the forearm, but a smaller falls seems likely
[33]. As mentioned above, biochemical indices of bone
turnover are increased in the third trimester, and more so
in women with multiple gestation.
According to birth rate report in 2005, 16.83 births per
1000 population in Iran and 22.32 births per 1000 popu-
lation in India were reported [34]. The fertility rate was
1.82 and 2.78 children per woman in Iran and India
respectively. It seems that with improving family planning
program and decreasing fertility rate, multiparity may not
be a risk factor of osteoporosis in next generation in two
countries.
Medical disorders and medication
Bone and joint problems (include any bone and joint dis-
comfort that need treatment) have been shown as a risk
factor of osteoporosis in Iranian and Indian subjects. The
reason is probably effect of some diseases like rheumatoid
arthritis, drugs like steroids and lack of ability for physical
activity on osteoporosis.
Calcium supplementation
Prospective data show that calcium stabilized bone [35].
To prevent negative calcium balance, premenopausal
women require 1000 mg and postmenopausal women
1200 mg of total elemental calcium daily [36]. In this
study use of calcium supplements has been shown as a
protective factor for osteoporosis in Iran. Use of calcium
supplements more than 1 year has been shown as a pro-
tective factor in India.
HRT and Steroids
Estrogen deficiency after menopause predictably leads to
bone loss and osteoporosis. Estrogen inhibits bone
resorption produces a small rise in bone density, and
reduces the risk of fracture by approximately 50 percent
[37-39]. Accordingly, HRT is the accepted standard of
practice for the prevention and for the treatment of oste-
oporosis. HRT and medication with steroids In Iran have
been shown as protective and risk factor of osteoporosis
respectively. In India percentage of women that were
under HRT were higher in control group and percentage
of women that use steroids were higher in osteoporotic
group but these were not significant statistically. The
probable reasons include:
a) Small number of women that were under HRT or ster-
oid treatment in Indian subjects.
b) Use of HRT as a treatment after osteoporosis.
Nutritional factors
The role of nutrition is perhaps the most controversial
area in the causation of Osteoporosis. Calcium, phos-
phate, and vitamin D are essential for normal bone struc-
ture and function, but several other micronutrients also
have essential roles in bone mass. Non nutrients such as
phytoestrogens may also improve the status of bone tissue
[40], Guthrie reports that women whose diets meet their
calcium recommendation consume significantly more
servings of milk and milk products and more several
essential nutrients than women whose diet do not meet
their calcium needs [41]. In India, nil consumption of
milk, have been shown as risk factors of osteoporosis, In
Iran, daily consumption of milk and cheese =>30 g/d have
been shown as protective factors of osteoporosis. Also the
consumption of almond, Soya products, were shown as
protective factors in India [42]. Almond was also reported
as good sources of calcium in literature. The isoflavones in
soybeans, which function both as phytoestrogens and
antioxidants, may result in the inhibition of bone resorp-
tion [43,44].
Vegetarian diets may be more beneficial than animal pro-
tein diet in many respects. But they may also contribute to
a lower life time exposure to estrogen, which could
increase the risk of osteoporotic fractures in vulnerable
individuals, which could increase the risk of osteoporotic
fractures in vulnerable individuals [45]. Some studies con-
firmed that there is no difference in bone health indices
between lacto-ovo-vegetarians and omnivores and some
of the studies propounded vegetarian diet as a risk factor
for osteoporosis [46]. In this study pure vegetarianism has
been shown as a risk factor of osteoporosis in India,
although it was not significant after weight and height
adjustment.
Present study also indicated that red meat consumption
more than 4 times per week was a risk factor among Ira-
nian subjects unlike chicken consumption more than 2
times per week that was shown as a protective factor.
Excessive protein consumption may lead to increased uri-
nary calcium excretion. Although high calcium intakes are
not significantly affected by a high protein intake, low cal-
cium intakes are generally not sufficient to offset a high
protein intake. Also important is total protein in the diet.
Low levels of serum albumin negatively affect transport of
serum calcium. Fracture patients may be especially vulner-
able to the relationship between low calcium and high
protein intakes [46].
Protective role of chicken, fish and egg at present study in
Iran confirm the theory of "adequate protein intake is
important for optimal bone health in the elderly 50–69BMC Musculoskeletal Disorders 2008, 9:28 http://www.biomedcentral.com/1471-2474/9/28
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years of age". But red meat consumption 4 times or more
per week was shown as a risk factor in Iranian population.
The most probably reasons are as follow:
1 – People who use fish and chicken more than 2 times
per week are those who are following medical healthy diet
with balance in red meat and white meat consumption.
Thus their dietary pattern is not associated with excessive
consumption of protein.
2 – Red meat and white meat probably have different bio-
logical effects on bone mass. For example there is higher
proportion of phosphorous in red meat that may affect
bone mass [46]. However this theory needs to be con-
firmed with other studies.
According to previous studies, higher fruit and vegetable
intake was associated with greater BMD in men and
women [47,48]. In this study daily consumption of fruits
was shown as a protective factor in Iranian and Indian
subjects. There was no significant association with vegeta-
ble consumption and osteoporosis in Iran and India.
In this study black tea consumption more than 6 cups per
day in Iran and Milk tea consumption 4 cups per day or
more in India have been shown as protective factors for
osteoporosis. Similar results have been reported in some
previous studies [49]. Nutrients found in tea, such as fla-
vonoids, may influence BMD [50].
Physical activity and Exercise
Exercises have been shown as a protective factor in both
countries. Recent evidence indicates that some forms of
physical activity may maintain or even increase BMD in
selected population [51,52]. Weight bearing exercise and
muscle contraction combined have been shown to effec-
tively increase bone density in the spine. It is recom-
mended that an individual perform 20 to 30 minutes of
aerobic exercise 3 to 4 times weekly to increase bone mass.
Simple exercises such as walking can help strengthen
bones and muscles there is strong evidence that physical
activity begun early in life contributes to higher peak bone
mass [19,53]. In this study women with no regular walk-
ing were in more risk of osteoporosis in Iran. There was no
significant protective role in walking or the time and dura-
tion of walking in Indian subjects. Other kinds of exer-
cises like aerobic, swimming, weight lifting and others
have been shown as a protective factor in Iran.
Anthropometric Factors
High weight is a protective factor for osteoporosis, in
obese individuals; fracture risk is reduced [40]. In this
study weight less than 60 kg and BMI less than 26 have
been shown as risk factors of osteoporosis in both coun-
tries. Height less than 155 cm have been shown as a risk
factor of osteoporosis in Indian subjects and in private
center of Iran. The role of anthropometric factors was
reported in previous studies [54].
Habits
Cigarette smoking is a risk factor for vertebral, forearm
and hip fractures. Women who smoke enter menopause 1
to 2 years earlier and lose bone more rapidly than non
smokers [55]. Women who smoke about one pack of cig-
arettes daily will have an average deficit of 5% to 10% in
bone density which increase the risk of fracture [40] in
this study Frequency of smoking at least one per day in
Iranian subjects were 9% (6% in osteoporotic group and
12% in controls), in Indian subjects it was 2.6% in total.
The effective amount of cigarette smoking on osteoporo-
sis is at least 10 cigarettes per day and its frequency were
3.6% and 1.4% respectively in Iran and India thus it
seems because of small amount of smoking per day it does
not show any effect on osteoporosis in both populations.
Fracture history
the major problem related to osteoporosis is fracture and
the significant association between history of fracture with
low bon density and osteoporosis are well described in
previous studies [30,54] in present study also we have
found the same results in both countries.
Conclusion
Osteoporosis in Iranian and Indian subjects also appears
to be associated with several known risk factors that well
described in the literature. There were no significant dif-
ferences in association of risk factors and osteoporosis
between Iranian and Indian subjects.
It was shown a protective role of certain nutritional die-
tary components and also exercises in both populations
and can be exploited in preventive educational strategies
on osteoporosis in these populations
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